GIANT CELL ARTERITIS (GCA)
Clinical trials for GIANT CELL ARTERITIS (GCA) explained in plain language.
Never miss a new study
Get alerted when new GIANT CELL ARTERITIS (GCA) trials appear
Sign up with your email to follow new studies for GIANT CELL ARTERITIS (GCA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can patients stop their powerful arthritis drug? new study aims to find out
Disease control Recruiting nowThis study is for people with giant cell arteritis (GCA) whose disease is under control after at least a year of treatment. It aims to see if they can safely stop or reduce their current medication (tocilizumab) without the disease coming back. About 78 participants will be rando…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Two-Pill combo aims to shield fragile vessels from heart attacks
Disease control Recruiting nowThis study is testing if two existing blood pressure medications can improve blood vessel health and reduce the risk of heart disease in people with large vessel vasculitis (LVV). Sixty participants, including people with LVV in remission and healthy volunteers, will take the dru…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: PHASE2 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
Blood test could end arthritis medication guesswork
Diagnosis Recruiting nowThis study is testing a new blood test designed to predict which arthritis medications will work best for individual patients before they start treatment. Researchers will analyze blood samples from 120 people with various autoimmune rheumatic diseases to see if the test can accu…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Sponsor: University of Bonn • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC
-
Simple blood test could spare patients from unnecessary scans for dangerous condition
Diagnosis Recruiting nowThis study is testing whether a blood test measuring a protein called thrombomodulin can accurately tell which patients with polymyalgia rheumatica (PMR) also have a more serious condition called giant cell arteritis (GCA). Researchers will enroll 78 adults over 50 with PMR to se…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
Simple eye scan could speed diagnosis of dangerous blood vessel disease
Diagnosis Recruiting nowThis study is testing whether measuring the sheath around the optic nerve using a simple, non-invasive ultrasound can help doctors diagnose giant cell arteritis (GCA) more quickly and accurately. GCA is a serious inflammatory condition of blood vessels that mainly affects older a…
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: NA • Sponsor: Hôpital NOVO • Aim: Diagnosis
Last updated Mar 27, 2026 12:41 UTC
-
Trial tests if 'Steroid Withdrawal' fatigue can be treated
Symptom relief Recruiting nowThis study aims to see if a low-dose steroid (hydrocortisone) can help people who feel very tired and unwell after they stop taking stronger steroids for conditions like polymyalgia rheumatica or giant cell arteritis. It will involve 100 patients who have recently finished their …
Matched conditions: GIANT CELL ARTERITIS (GCA)
Phase: PHASE4 • Sponsor: Marianne Andersen • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC